The Business
Research Company published its Anti-Viral Drug Therapy Global Market Report
2020 which provides strategists, marketers and senior management with the
critical information they need to assess the global Anti-Viral Drug Therapy
market. The report provides in-depth analysis of the impact of COVID-19 on the
market, along with revised market numbers due to the effects of the
coronavirus.
The report covers the Anti-Viral Drug
Therapy market’s segments-
1) By Drug
Class: DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease
Inhibitors, Neuraminidase Inhibitors, Others
2) By
Application: HIV, Hepatitis, Herpes, Influenza, Others.
View Complete Report:
Anti-Viral Drug Therapy Global Market Report 2020 is the
most comprehensive report available on this market and will help gain a truly
global perspective as it covers 60 geographies. The chapter on the impact of
COVID-19 gives valuable insights on supply chain disruptions, logistical
challenges, and other economic implications of the virus on the market. The
chapter also covers markets which have been positively affected by the
pandemic.
The global anti-viral drug therapy market is expected to
grow from $52.2 billion in 2019 to about $59.9 billion in 2020 as there is a
surge in demand for antiretroviral drugs used in the treatment of COVID-19
patients. The market is expected to stabilize and reach $62.6 billion at a CAGR
of 4.6% through 2023.
Companies in the anti-viral drug therapy market are
continuously innovating through technological advancements to develop drugs to
treat different viral infections. Biopharmaceutical companies are developing
vaccines for the treatment of novel coronavirus. Technological advances in the
pharmaceutical sector include development of nucleic acid vaccines that are
DNA- and RNA-based, and which enable the human body to produce the vaccine
antigen.
Few Points From Table Of Content
1. Executive
Summary
2.
Anti-Viral Drug Therapy Market Market Characteristics
3.
Anti-Viral Drug Therapy Market Market Size And Growth
4.
Anti-Viral Drug Therapy Market Market Segmentation
5.
Anti-Viral Drug Therapy Market Market Regional And Country Analysis
......
25.
Anti-Viral Drug Therapy Market Market Competitive Landscape And Company Profiles
26. Key
Mergers And Acquisitions In The Anti-Viral Drug Therapy Market Market
27.
Anti-Viral Drug Therapy Market Market Trends And Strategies
28.
Anti-Viral Drug Therapy Market Market Future Outlook and Potential Analysis
29. Appendix
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2831&type=smp
Few Points From List Of Tables
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F,
2025F, 2030F, $ Billion
Table 3: Global Anti-Viral Drug Therapy Market Market,
Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2023F, 2025F,
2030F, $ Billion
Table 4: Global Anti-Viral Drug Therapy Market Market,
Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F,
2030F, $ Billion
………
Table 27: Bristol-Myers-Squibb Financial Performance
Table 28: Cipla
Financial Performance
Table 29: F. Hoffmann-La Roche Ltd Financial Performance
Table 30: Gilead Sciences Inc Financial Performance
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
